Heartworm Prevention Medication (Oral/Topical) — pet safety profile
Low riskMonthly heartworm prevention medications for dogs and cats containing ivermectin, milbemycin oxime, moxidectin, or selamectin.
What is this product?
Monthly heartworm prevention medications for dogs and cats containing ivermectin, milbemycin oxime, moxidectin, or selamectin. FDA-approved veterinary drugs with established safety profiles. Ivermectin is neurotoxic to dogs with MDR1 gene mutation (Collies, Australian Shepherds, Shelties). Human handling risk is minimal but children should not handle.
What's in it
Click any compound name for its full safety profile, regulatory consensus, and exposure data.
Active Ingredient
Who's most at risk
- Children — Developing endocrine and neurological systems, higher exposure per body weight
Red flags — when to walk away
- Product not veterinarian-recommended or approved — Unverified safety and efficacy for intended use.
Green flags — what to look for
- NASC quality seal or veterinary recommendation — Third-party quality verification and professional endorsement.
Safer alternatives
- Milbemycin oxime-based prevention for MDR1-sensitive breeds — Safer option
- Veterinary-prescribed alternatives based on breed testing — Safer option
- Monthly topical prevention — selamectin) for oral-averse pets
Frequently asked questions
Who should be careful with Heartworm Prevention Medication (Oral/Topical)?
Vulnerable populations identified for this product type: children.
Are there safer alternatives to Heartworm Prevention Medication (Oral/Topical)?
Yes — consider: Milbemycin oxime-based prevention for MDR1-sensitive breeds; Veterinary-prescribed alternatives based on breed testing; Monthly topical prevention. See the Safer alternatives section above for details.
Look up Heartworm Prevention Medication (Oral/Topical) in the pets app
Search by ingredient, browse by category, or compare to alternatives in the live app.
Open in pets View raw API dataReference data, not professional advice. Aggregates publicly available regulatory and scientific information. Why we built ALETHEIA →